AP511A - The use of granisetron in the manufacture of a medicament for the treatment of post-operative nausea advomiting (PONV). - Google Patents

The use of granisetron in the manufacture of a medicament for the treatment of post-operative nausea advomiting (PONV). Download PDF

Info

Publication number
AP511A
AP511A APAP/P/1994/000626A AP9400626A AP511A AP 511 A AP511 A AP 511A AP 9400626 A AP9400626 A AP 9400626A AP 511 A AP511 A AP 511A
Authority
AP
ARIPO
Prior art keywords
placebo
granisetron
vomiting
ponv
nausea
Prior art date
Application number
APAP/P/1994/000626A
Other languages
English (en)
Other versions
AP9400626A0 (en
Inventor
Gareth John Sanger
Phillip Timothy Davey
Christopher Stuart Dott
Original Assignee
Smithkline Beecham Plc
F Foffmann La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10732290&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AP511(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Plc, F Foffmann La Roche Ag filed Critical Smithkline Beecham Plc
Publication of AP9400626A0 publication Critical patent/AP9400626A0/xx
Application granted granted Critical
Publication of AP511A publication Critical patent/AP511A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Treatment Of Sludge (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
APAP/P/1994/000626A 1993-03-18 1994-03-16 The use of granisetron in the manufacture of a medicament for the treatment of post-operative nausea advomiting (PONV). AP511A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939305593A GB9305593D0 (en) 1993-03-18 1993-03-18 Pharmaceuticals

Publications (2)

Publication Number Publication Date
AP9400626A0 AP9400626A0 (en) 1994-04-30
AP511A true AP511A (en) 1996-07-26

Family

ID=10732290

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1994/000626A AP511A (en) 1993-03-18 1994-03-16 The use of granisetron in the manufacture of a medicament for the treatment of post-operative nausea advomiting (PONV).

Country Status (20)

Country Link
US (1) US5952340A (de)
EP (1) EP0689437B1 (de)
JP (2) JP3792251B2 (de)
KR (1) KR100315606B1 (de)
CN (1) CN1085079C (de)
AP (1) AP511A (de)
AT (1) ATE230596T1 (de)
AU (1) AU676032B2 (de)
CA (1) CA2158354C (de)
CY (1) CY2427B1 (de)
DE (1) DE69431986T2 (de)
DK (1) DK0689437T3 (de)
ES (1) ES2188611T3 (de)
GB (1) GB9305593D0 (de)
HU (1) HU214629B (de)
IL (1) IL109059A (de)
SG (1) SG46724A1 (de)
TW (1) TW312622B (de)
WO (1) WO1994021257A1 (de)
ZA (1) ZA941844B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9412995D0 (en) * 1994-06-28 1994-10-26 Prendergast Kenneth F Safety enhancing pharmaceutical compositions of an active indazole
WO2003100091A1 (en) * 2002-05-24 2003-12-04 Epidauros Biotechnologie Ag Means and methods for improved treatment using 'setrones'
SE0203410D0 (sv) * 2002-11-18 2002-11-18 Astrazeneca Ab New use
JO2735B1 (en) * 2003-01-30 2013-09-15 هيلسين هيلث كير أس ايه. Liquid pharmaceutical formulations of palonosetron
MY143789A (en) 2003-02-18 2011-07-15 Helsinn Healthcare Sa Use of palonosetron treating post- operative nausea and vomiting
GB0328186D0 (en) * 2003-12-05 2004-01-07 West Pharm Serv Drug Res Ltd Intranasal compositions
JP6081102B2 (ja) * 2012-08-10 2017-02-15 テルモ株式会社 安定なグラニセトロン含有水性製剤
GB201618425D0 (en) * 2016-11-01 2016-12-14 Acacia Pharma Ltd method
JP2017077484A (ja) * 2016-11-30 2017-04-27 テルモ株式会社 安定なグラニセトロン含有水性製剤の包装体
GB201702250D0 (en) 2017-02-10 2017-03-29 Acacia Pharma Ltd Method

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3650772T2 (de) * 1985-04-27 2003-04-03 F. Hoffmann-La Roche Ag, Basel Derivate von Indazole-3-carboxamide und -3-carboxylsäure
GB8525913D0 (en) * 1985-10-21 1985-11-27 Beecham Group Plc Compounds
GB8928837D0 (en) * 1989-12-21 1990-02-28 Beecham Group Plc Pharmaceuticals
US5225407A (en) * 1990-02-22 1993-07-06 Glaxo Group Limited 5-HT3 receptor antagonists for the treatment of autism
DE69231395T3 (de) * 1991-09-20 2005-07-21 Glaxo Group Ltd., Greenford Neue medizinische Indikation für Tachykinin-Antagonisten

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NONE *

Also Published As

Publication number Publication date
JPH08507774A (ja) 1996-08-20
ES2188611T3 (es) 2003-07-01
TW312622B (de) 1997-08-11
IL109059A (en) 1996-11-14
HU214629B (hu) 1998-04-28
EP0689437B1 (de) 2003-01-08
HU9502692D0 (en) 1995-11-28
ZA941844B (en) 1995-09-18
AU6377494A (en) 1994-10-11
CA2158354A1 (en) 1994-09-29
DE69431986D1 (de) 2003-02-13
DK0689437T3 (da) 2003-04-28
CY2427B1 (en) 2004-11-12
JP2006083190A (ja) 2006-03-30
HUT73502A (en) 1996-08-28
CN1085079C (zh) 2002-05-22
SG46724A1 (en) 1998-02-20
IL109059A0 (en) 1994-11-28
EP0689437A1 (de) 1996-01-03
ATE230596T1 (de) 2003-01-15
HK1012237A1 (en) 1999-07-30
AU676032B2 (en) 1997-02-27
GB9305593D0 (en) 1993-05-05
DE69431986T2 (de) 2003-11-06
JP3792251B2 (ja) 2006-07-05
CN1122570A (zh) 1996-05-15
KR100315606B1 (ko) 2002-04-24
AP9400626A0 (en) 1994-04-30
US5952340A (en) 1999-09-14
CA2158354C (en) 2004-07-13
WO1994021257A1 (en) 1994-09-29

Similar Documents

Publication Publication Date Title
CA1288350C (en) Controlled release dihydrocodeine composition
KR940011246B1 (ko) 로라타딘, 이부프로펜 및 슈도에페드린을 함유하는 약제학적 조성물
US20040234593A1 (en) Diphenhydramine tannate compositions and methods of use
DE60009697T2 (de) Verwendung von 1-[4-(5-cyanoindol-3yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazin und dessen physiologisch akzeptablen salzen zur behandlung von bipolaren krankheiten und manie
DE19858789A1 (de) Kombination von Cerivastatin und Fibraten
AP511A (en) The use of granisetron in the manufacture of a medicament for the treatment of post-operative nausea advomiting (PONV).
NZ504656A (en) Substituted aminomethyl-chromans are used for the regenerative treatment of neurological conditions which are the sequelae of damage due to surgical intervention, exposure to toxic agents, infections, tumours, and other diseases and conditions
JPH0320222A (ja) 脳内虚血症治療剤
US20060160887A1 (en) Medicinal composition
HK1012237B (en) Use of granisetron for the treatment of post-operative nausea and vomiting
CZ282168B6 (cs) Oční místní prostředek obsahující hemihydrát (S)-timololu, jeho použití a způsob jeho přípravy
CA2002552C (en) Pharmaceutical aqueous solution for ophthalmic use comprising a water solube pharmaceutically acceptable acid addition salt of ibopamine
CN1146420C (zh) [R－（Z）]-a-（甲氧基亚氨基）-a-（1－氮杂双环[2.2.2]辛－3－基）乙腈在制备治疗精神病的药物中的应用
JP3150642B2 (ja) 新規な抗痙攣性及び抗炎症性組成物並びにそれらの製造方法
WO1998038997A1 (en) Use of levobupivacaine in combination with opiods or alfa2-agonists for providing anaesthesia or analgesia
US4062974A (en) Method for treating drepanocytosis
US6162792A (en) Use of spiramycin for treating gastrointestinal disorders caused by H. pylori
JP2001181206A (ja) 去痰効果が増強された固形剤
US5990134A (en) Oral droperidol compositions and method for treating migraine
EP0723448A1 (de) Verwendung von peniclorin zur behandlung von postherpetischer neuralgie
JPH0132804B2 (de)
JP2001253825A (ja) 帯状疱疹後神経痛用鎮痛剤
MXPA01000466A (en) Method of treatment